Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2018-07-14
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs.
Methods: This single-center, retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making. The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect, based on measurements from transthoracic and transesophageal ultrasound.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE Assessment
NCT02601768
Improvement In Left Ventricular Diameter After Closure Of ASD With Fenestrated Patch: A Cross-sectional Study
NCT06139679
Holter and ECG Changes After Trancatheter Closure Of ASD In Children
NCT06197191
Cardiac Function After Transcatheter VSD Closure
NCT03127748
Holter and ECG Changes After Transcatheter Closure Of ASD In Children
NCT05540769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs.
Methods: This single-center, retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making. The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect, based on measurements from transthoracic and transesophageal ultrasound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Zero fluoroscopy oval-shaped secundum ASD closure
Zero-fluoroscopy ASD closure
Percutaneous ASD closure without fluoroscopy was performed in secundum-type oval-shaped ASD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zero-fluoroscopy ASD closure
Percutaneous ASD closure without fluoroscopy was performed in secundum-type oval-shaped ASD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cardiovascular Center Harapan Kita Hospital Indonesia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cardiovascular Center Harapan Kita
Jakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LB.02.01/VII/020/KEP020/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.